Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
531349 | BSE
-6.00
-3.42%
Healthcare
Biotechnology
31/03/2023
08/12/2023
169.60
176.85
176.85
167.55
Panacea Biotec Limited a biotechnology company researches and develops manufactures markets and sells pharmaceuticals vaccines and biosimilar in India. The company operates through Vaccines Formulations and Research and Development segments. Its product portfolio includes prescription products in various therapeutic areas including pain management diabetes and cardiovascular management oncology renal disease management osteoporosis management anti-tubercular and gastro-intestinal care products as well as vaccines. The company also exports its products to the Commonwealth of Independent States Africa the Middle East and Asia. It has a collaboration agreement with Refana Inc. for the development manufacturing and distribution of the Covid-19 vaccine. Panacea Biotec Limited was founded in 1984 and is based in New Delhi India.
View LessPositive Momentum
High Short-term Volatility
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
52.3%1 month
40.5%3 months
51.4%6 months
54.3%17.46
0
3.86
0.51
0.34
6.49
3.08
0
998.60M
11.70B
140.32M
1.82
9.12
0
0
-192.75
0
0
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
22.05
Range1M
28.40
Range3M
52.85
Rel. volume
0.66
Price X volume
2.73M